Search

Your search keyword '"Viatris Inc. -- Forecasts and trends"' showing total 11 results
Start Over Descriptor "Viatris Inc. -- Forecasts and trends" Publication Year Range This year
11 results on '"Viatris Inc. -- Forecasts and trends"'

1. Epinephrine Autoinjector Market to Grow by USD 2.44 Billion (2024-2028), Driven by Rising Allergy Prevalence and AI-Powered Market Transformation - Technavio

Subjects
United States. Food and Drug Administration, Viatris Inc. -- Forecasts and trends, Allergic reaction -- Forecasts and trends, Allergy -- Forecasts and trends, Epinephrine -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Report with the AI impact on market trends - The global epinephrine autoinjector market size is estimated to grow by USD [...]

Published
2024

2. Night Vision Disturbance Market Size was highest in the US among the 7MM, accounting for ~USD 1,754 Million which is further expected to rise at CAGR of 1.08% by 2034, estimated DelveInsight

Subjects
Viatris Inc. -- Forecasts and trends, Business -- Research, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-December 4, 2024-: Night Vision Disturbance Market Size was highest in the US among the 7MM, accounting for ~USD 1,754 Million which is further expected to rise at CAGR [...]

Published
2024

3. Viatris Inc (VTRS:NAS) Company Profile: Analytics, Extensive Financial Metrics, and Benchmark Against Averages and Top Companies Within its Industry

Subjects
Viatris Inc. -- Forecasts and trends, Plunkett Research, Ltd. -- Forecasts and trends, Financial analysis -- Forecasts and trends -- Reports, Marketing research firms -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - The 'Viatris Inc (VTRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry' company profile from Plunkett Research Ltd has been added to [...]

Published
2024

4. Bronchial Spasm Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight

Subjects
Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Amphastar Pharmaceuticals -- Forecasts and trends, Business -- Research, Bronchial spasm -- Forecasts and trends, Brand equity -- Forecasts and trends, Drug approval -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 10, 2024-: Bronchial Spasm Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:10062024 Bronchial Spasm companies are GlaxoSmithKline, Merck Sharp [...]

Published
2024

5. Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

Subjects
Viatris Inc. -- Forecasts and trends, Sustainability reporting -- Reports -- Forecasts and trends, Environmental sustainability -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 22, 2024-: Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale (C)1994-2024 M2 COMMUNICATIONS RDATE:21052024 * Company continues to supply high-quality medicines to approximately 1 billion patients [...]

Published
2024

6. Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

Subjects
Viatris Inc. -- Forecasts and trends, World health -- Forecasts and trends -- Reports, Sustainability reporting -- Reports -- Forecasts and trends, Environmental sustainability -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

Company continues to supply high-quality medicines to approximately 1 billion patients annually Report chronicles Viatris' commitment to providing access to healthcare and building healthier communities Impactful story highlights include 'Empathy [...]

Published
2024

7. Active Pharmaceutical Ingredient Market Worth $238.3 billion

Subjects
Merck KGaA -- Forecasts and trends, Cambrex Corp. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Specialty chemicals industry -- Statistics -- Forecasts and trends, Industrial research -- Germany -- United States -- United Kingdom -- India, Pharmaceutical industry -- Statistics -- Forecasts and trends, Research and development, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

CHICAGO: MarketsandMarkets has issued the following news release: Active Pharmaceutical Ingredient Market in terms of revenue was estimated to be worth $163.5 billion in 2024 and is poised to reach [...]

Published
2024

8. Intrauterine Contraceptive Devices (IUD) Market to grow by USD 965.49 million at a CAGR of 3.98% from 2022 to 2027, AbbVie Inc. and Bayer AG are among the key companies

Subjects
Cooper Companies Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Eyewear industry -- Forecasts and trends, Contraceptives -- Forecasts and trends, Contraceptives industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The intrauterine contraceptive devices (IUD) market is estimated to grow by USD 965.49 million from 2023 to 2027 at a CAGR [...]

Published
2024

9. Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio

Subjects
Bayer AG -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Anika Therapeutics Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Novartis AG -- Forecasts and trends, Horizon Therapeutics PLC -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Zimmer Biomet Holdings, Inc. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Antiarthritic agents -- Forecasts and trends, Osteoarthritis -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 16, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/osteoarthritis-therapeutics-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk03_2024_016_rep&utm_content=IRTNTR43212 size is expected to grow byUSD 3.96 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Published
2024

10. Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth - Technavio

Subjects
Merck KGaA -- Forecasts and trends, Shionogi & Company Ltd. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Torii Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Optum Inc. (White Plains, New York) -- Forecasts and trends, Computer software industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Immunotherapy -- Forecasts and trends, Ciclesonide -- Forecasts and trends, Allergic reaction -- Forecasts and trends, Allergy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 15, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/allergy-immunotherapies-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk03_2024_019_rep&utm_content=IRTNTR41320 is expected to grow byUSD 1.01 billion from 2022 to 2027. In addition, the momentum of the market will progress at aCAGR [...]

Published
2024

11. Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of market growth - Technavio

Subjects
Cambrex Corp. -- Forecasts and trends, Indena S.p.A. -- Forecasts and trends, Koninklijke DSM N.V. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Apotex Inc. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Thermo Fisher Scientific Inc. -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Scientific equipment and supplies industry -- Forecasts and trends, Specialty chemicals industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The https://www.technavio.com/report/active-pharmaceutical-ingredients-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week1_24_TI_019_rep&utm_content=IRTNTR40608 is expected to grow byUSD 86.47 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results